Trial Process

Future of Sullivan & Cromwell at SCOTUS

Supreme Court Bar Future: Sullivan & Cromwell’s Morgan Ratner in Spotlight

The future of the Supreme Court bar is taking shape, with rising stars like Morgan Ratner of Sullivan & Cromwell at the forefront of this evolution. As the landscape of Supreme Court advocacy continues to shift, Ratner’s ascent highlights the changing dynamics within this elite group of legal professionals. Her work at Sullivan & Cromwell, […]

Supreme Court Bar Future: Sullivan & Cromwell’s Morgan Ratner in Spotlight Read More »

Tyco BASF PFAS Settlement Victory

PFAS Foam Litigation: Attorneys Secure $95.8M in Tyco, BASF Settlements

In a landmark development for environmental litigation, attorneys have secured substantial settlements totaling $95.8 million from Tyco and BASF in the ongoing PFAS foam litigation. This significant legal victory marks a crucial step forward in addressing the widespread contamination caused by per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals” due to their

PFAS Foam Litigation: Attorneys Secure $95.8M in Tyco, BASF Settlements Read More »

Natera Guardant Legal Battle

Natera vs. Guardant: Jury Awards $292.5M in False Advertising Lawsuit

In a landmark decision that has sent shockwaves through the biotech industry, a federal court jury has unanimously ruled in favor of Guardant Health in its false advertising lawsuit against Natera, awarding a staggering $292.5 million in damages. This verdict, which includes $175.5 million in punitive damages, represents one of the largest false advertising judgments

Natera vs. Guardant: Jury Awards $292.5M in False Advertising Lawsuit Read More »

CVS Fails to Preempt False Ad Lawsuit

CVS False Advertising Lawsuit: Preemption Bid Fails in ‘Non-Drowsy’ Case

In a significant legal development, CVS Pharmacy Inc. has failed to convince a federal judge that federally approved labels for over-the-counter cold medicines preempt a consumer’s proposed class action lawsuit alleging false advertising of their ‘non-drowsy’ labeling. This case highlights the ongoing challenges faced by pharmaceutical retailers in navigating the complex landscape of product labeling

CVS False Advertising Lawsuit: Preemption Bid Fails in ‘Non-Drowsy’ Case Read More »

Scroll to Top